Kuros Biosciences AG Company Description
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally.
It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold to be implanted in any intervertebral disc space or posterolateral spine level; and Magnetos Flex Matrix, an open matrix bone graft.
Its Fibrin-PTH pipeline products comprise KUR-111 and KUR-113 that are in Phase 2b clinical trials for trauma indications; KUR-113 that is in Phase 2a clinical trial for spinal indications.
The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Country | Switzerland |
Founded | 2016 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 80 |
CEO | Christopher Fair |
Contact Details
Address: Wagistrasse 25 Schlieren, 8952 Switzerland | |
Phone | 41 44 733 4747 |
Website | kuros.ch |
Stock Details
Ticker Symbol | 0RHR |
Exchange | London Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CHF |
ISIN Number | CH0325814116 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Prof. Joost D. de Bruijn B.S., Ph.D., B.Sc. Ph.D. | Chief Executive Officer and Director |
Michael Grau M.B.A., MBA | Chief Financial Officer |
Dr. Alistair Irvine | Chief Business Officer |
Dr. Philippe Saudan Ph.D. | Chief Development Officer |
Frank-Jan van der Velden MBA | Head of Business Affairs and Finance of Kuros Biosciences B.V. |
Dr. Pascal Longlade | Chief Medical Officer |
Dr. Oliver P. Kronenberg | Senior Legal Counsel |
Dr. Charlie Campion | Senior Vice President of Marketing and International Sales |
John Griffin | Head of Commercial Operations |
Florence Barrere de Groot | Head of Development |